Cargando…

Challenges of an Emerging Disease: The Evolving Approach to Diagnosing Devil Facial Tumour Disease

Devil Facial Tumour Disease (DFTD) is an emerging infectious disease that provides an excellent example of how diagnostic techniques improve as disease-specific knowledge is generated. DFTD manifests as tumour masses on the faces of Tasmanian devils, first noticed in 1996. As DFTD became more preval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Espejo, Camila, Patchett, Amanda L., Wilson, Richard, Lyons, A. Bruce, Woods, Gregory M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780694/ https://www.ncbi.nlm.nih.gov/pubmed/35055975 http://dx.doi.org/10.3390/pathogens11010027

Ejemplares similares

Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease
por: Tovar, Cesar, et al.
Publicado: (2018)

The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell Lines
por: Patchett, Amanda L., et al.
Publicado: (2016)

Tasmanian devil cathelicidins exhibit anticancer activity against Devil Facial Tumour Disease (DFTD) cells
por: Petrohilos, Cleopatra, et al.
Publicado: (2023)

Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils
por: Pye, Ruth, et al.
Publicado: (2016)

Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils
por: Tovar, Cesar, et al.
Publicado: (2017)

Transcriptome and proteome profiling reveals stress-induced expression signatures of imiquimod-treated Tasmanian devil facial tumor disease (DFTD) cells
por: Patchett, Amanda L., et al.
Publicado: (2018)

Immunization Strategies Producing a Humoral IgG Immune Response against Devil Facial Tumor Disease in the Majority of Tasmanian Devils Destined for Wild Release
por: Pye, Ruth, et al.
Publicado: (2018)

Class II transactivator induces expression of MHC-I and MHC-II in transmissible Tasmanian devil facial tumours
por: Ong, Chrissie E. B., et al.
Publicado: (2022)

New Insights into the Role of MHC Diversity in Devil Facial Tumour Disease
por: Lane, Amanda, et al.
Publicado: (2012)

Comparative Analysis of Immune Checkpoint Molecules and Their Potential Role in the Transmissible Tasmanian Devil Facial Tumor Disease
por: Flies, Andrew S., et al.
Publicado: (2017)

Identification of candidate genes for devil facial tumour disease tumourigenesis
por: Taylor, Robyn L., et al.
Publicado: (2017)

Inducible IFN-γ Expression for MHC-I Upregulation in Devil Facial Tumor Cells
por: Ong, Chrissie E. B., et al.
Publicado: (2019)

Gomesin peptides prevent proliferation and lead to the cell death of devil facial tumour disease cells
por: Fernandez-Rojo, Manuel A., et al.
Publicado: (2018)

The newly-arisen Devil facial tumour disease 2 (DFT2) reveals a mechanism for the emergence of a contagious cancer
por: Caldwell, Alison, et al.
Publicado: (2018)

Mouse Model of Devil Facial Tumour Disease Establishes That an Effective Immune Response Can be Generated Against the Cancer Cells
por: Pinfold, Terry L., et al.
Publicado: (2014)

Untangling the model muddle: Empirical tumour growth in Tasmanian devil facial tumour disease
por: Hamede, Rodrigo K., et al.
Publicado: (2017)

Expression of the Nonclassical MHC Class I, Saha-UD in the Transmissible Cancer Devil Facial Tumour Disease (DFTD)
por: Hussey, Kathryn, et al.
Publicado: (2022)

A Devil of a Transmissible Cancer
por: Woods, Gregory M., et al.
Publicado: (2020)

To Lose Both Would Look Like Carelessness: Tasmanian Devil Facial Tumour Disease
por: McCallum, Hamish, et al.
Publicado: (2006)

Tasman-PCR: a genetic diagnostic assay for Tasmanian devil facial tumour diseases
por: Kwon, Young Mi, et al.
Publicado: (2018)

Vincristine Chemotherapy Trials and Pharmacokinetics in Tasmanian Devils with Tasmanian Devil Facial Tumor Disease
por: Phalen, David N., et al.
Publicado: (2013)

Devil Facial Tumour Disease (DFTD): Using Genetics and Genomics to Investigate Infectious Disease in an Endangered Marsupial
por: Bender, Hannah S.
Publicado: (2010)

Isotopic niche variation in Tasmanian devils Sarcophilus harrisii with progression of devil facial tumor disease
por: Bell, Olivia, et al.
Publicado: (2021)

Global DNA Methylation patterns on marsupial and devil facial tumour chromosomes
por: Ingles, Emory D., et al.
Publicado: (2015)

Natural Killer Cell Mediated Cytotoxic Responses in the Tasmanian Devil
por: Brown, Gabriella K., et al.
Publicado: (2011)

The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor Disease
por: Kosack, Lindsay, et al.
Publicado: (2019)

Disruption of Metapopulation Structure Reduces Tasmanian Devil Facial Tumour Disease Spread at the Expense of Abundance and Genetic Diversity
por: Durrant, Rowan, et al.
Publicado: (2021)

How the devil facial tumor disease escapes host immune responses
por: Siddle, Hannah V, et al.
Publicado: (2013)

Identification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumors
por: Howson, Lauren J., et al.
Publicado: (2014)

The Devil's Advocate
por: Woods, Caspian
Publicado: (2013)

PD-L1 Is Not Constitutively Expressed on Tasmanian Devil Facial Tumor Cells but Is Strongly Upregulated in Response to IFN-γ and Can Be Expressed in the Tumor Microenvironment
por: Flies, Andrew S., et al.
Publicado: (2016)

Comparative Cytogenetic Mapping and Telomere Analysis Provide Evolutionary Predictions for Devil Facial Tumour 2
por: Ingles, Emory D., et al.
Publicado: (2020)

Variants in the host genome may inhibit tumour growth in devil facial tumours: evidence from genome-wide association
por: Wright, Belinda, et al.
Publicado: (2017)

Genomic Restructuring in the Tasmanian Devil Facial Tumour: Chromosome Painting and Gene Mapping Provide Clues to Evolution of a Transmissible Tumour
por: Deakin, Janine E., et al.
Publicado: (2012)

Correction: Genomic Restructuring in the Tasmanian Devil Facial Tumour: Chromosome Painting and Gene Mapping Provide Clues to Evolution of a Transmissible Tumour
Publicado: (2014)

The devil's in the details
por: Petsko, Gregory A
Publicado: (2010)

The devil is in the details: Genomics of transmissible cancers in Tasmanian devils
por: Storfer, Andrew, et al.
Publicado: (2018)

Emerging foodborne diseases: an evolving public health challenge.
por: Tauxe, R V
Publicado: (1997)

ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1)
por: Hayes, Dane A., et al.
Publicado: (2017)

The Challenges of Dialysis in Systemic Sclerosis: Between the Devil and the Deep Blue Sea?
por: Brown, N., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_a6dv542ks7u56raakn5bqj4ovn